The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis

Background: Compound Kushen Injection (CKI) is a Chinese patent medicine approved by the China Food and Drug Administration for the treatment of various types of solid tumors. CKI, combined with transarterial chemoembolization (TACE), is believed to increase the therapeutic efficacy of unresectable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Ma, Xiao, Li, Rui-Sheng, Wang, Jian, Huang, Yin-Qiu, Li, Peng-Yan, Wang, Ji, Su, Hai-Bin, Wang, Rui-Lin, Zhang, Ya-Ming, Liu, Hong-Hong, Zhang, Cong-En, Ma, Zhi-Jie, Wang, Jia-Bo, Zhao, Yan-Ling, Xiao, Xiao-He
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2016
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4814457/
https://ncbi.nlm.nih.gov/pubmed/27065861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00070
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados